Showing results (1721-1730 of 2,157) with videos related to

Sort By:
Pageof 216
Angewandte Chemie (International Ed. in English)|December 5, 2025
Co-Assemblies Regulate the Catalytic Activity of Peptide FibrilsAlbin Lahu, Shao-Lin Wu, Maximilian Schuler, et al.
Nature Communications|July 7, 2026
Prognostic RNA-splicing archetypes in breast cancer identified by extended pre-training of histopathology foundation modelsLisa Fournier, Garance Haefliger, Albin Vernhes, et al.
Journal of the American College of Emergency Physicians Open|September 27, 2021
Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deploymentThomas J Woltemate, Richard J Wadas, Erin K McCreary, et al.
Cancers|October 13, 2021
Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor ImmunityAlbin Jeanne, Thomas Sarazin, Magalie Charlé, et al.
Leukemia & Lymphoma|May 26, 1999
Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patientsC Soussain, B Souleau, J Gabarre, et al.
Psychoradiology|October 14, 2024
Impaired mitochondrial function in bipolar disorder and alcohol use disorder: a case study using <sup>18</sup>F-BCPP-EF PET imaging of mitochondrial Complex ITravis P Wigstrom, Stiven Roytman, Jeffrey L B Bohnen, et al.
Annals of Neurology|July 11, 2006
Unexpected abundance of pathological tau in progressive supranuclear palsy white matterVictoria Zhukareva, Sonali Joyce, Teresa Schuck, et al.
Transplantation|March 22, 2002
Ketorolac-based analgesia improves outcomes for living kidney donorsStephen J Freedland, Malou Blanco-Yarosh, Jennifer C Sun, et al.
Research Square|October 27, 2023
A pilot randomized controlled trial comparing nutritious meal kits and no-prep meals to improve food security and diet quality among food pantry clientsKelseanna Hollis-Hansen, Carolyn Haskins, Jessica Turcios, et al.
Rheumatology (Oxford, England)|October 2, 2020
Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatmentAlbin Björk, Rui Da Silva Rodrigues, Elina Richardsdotter Andersson, et al.
Pageof 216